Its relevance here stems from a clinical reality: autoimmune thyroid disease primarily Hashimoto's affects women at seven to ten times the rate of men, and is a leading cause of hypothyroidism, fatigue, weight gain, and menstrual irregularity in women aged 3060
The fundamental difference is that GLP-1 agonists eliminate hunger and create a state of pharmaceutical appetite suppression, while AOD-9604 leaves appetite entirely unchanged
Your PlexusDx clinician can determine whether combination therapy aligns with your metabolic profile and goals
The Ozempic weight loss litigation is moving forward, with Science Day set to take place soon
The goal is to support appetite control and weight loss while making treatment feel more manageable
While the drugs are widely reported as safe, theyre generally only studied in patients for up to a year